Please see below for today’s update on key Brexit news items:
- “Trade realities expose the absurdity of a Brexit ‘no deal’“, the FT reports. The article cites a recent World Bank study which argues that if the UK shifted from EU to WTO terms, trade in goods with the EU would halve and trade in services would fall 60 per cent. Financial Times
- The UK pharmaceutical sector has been told to prepare for a “crisis” Brexit scenario of drastically reduced access to European markets and hundreds of millions of pounds of restructuring costs unless a swift regulatory deal can be struck with Brussels. In a paper detailing how firms should prepare for Brexit, the European Medicines Agency advised UK-based pharma companies to move hundreds of roles and functions to an EU member state ahead of Brexit in order to maintain their existing rights to sell medicines in the common market. The Telegraph
- Jeremy Corbyn and Theresa May have outlined opposing strategies in terms of negotiating a Brexit deal. Labour has confirmed that walking away from Brexit negotiations if EU demands become too onerous would be “absurd” and that “there is no such thing as a no deal”, whilst Theresa May has reconfirmed her stance that “no deal is better than a bad deal”. The Guardian.
Jessica's practice focuses on international trade and anti-bribery work, encompassing customs, export control and sanctions matters.
Jessica's trade work includes advising international clients on fast-moving and evolving EU and UN sanctions, notably in respect of Iran and Russia, and on compliance with UK and EU export controls.
Her trade experience also includes advising on tariff classification and customs valuations.
Jessica's anti-bribery experience includes assisting with investigations, and advising clients on compliance with anti-bribery laws.
Jessica has also taken a lead role in monitoring Brexit-related developments; analysing how they will affect the UK's trading position generally, and clients' businesses specifically. She has helped clients begin to conduct risk assessments of how Brexit will impact their businesses, and has assisted them in developing tailored Brexit strategies. Jessica also presents at various seminars, webinars, and conferences on the complexities of Brexit.
Jessica advises global clients on complex issues arising from international transactions and works with clients across a number of sectors including pharmaceuticals, defence, finance, aviation, energy, and telecommunications.
Jessica has also worked previously in Paris, and is fluent in French.